JP2009515982A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009515982A5 JP2009515982A5 JP2008541306A JP2008541306A JP2009515982A5 JP 2009515982 A5 JP2009515982 A5 JP 2009515982A5 JP 2008541306 A JP2008541306 A JP 2008541306A JP 2008541306 A JP2008541306 A JP 2008541306A JP 2009515982 A5 JP2009515982 A5 JP 2009515982A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- syndrome
- hepatitis
- virus infection
- infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000056 organ Anatomy 0.000 claims description 5
- 201000007100 Pharyngitis Diseases 0.000 claims description 4
- 206010047115 Vasculitis Diseases 0.000 claims description 4
- 206010000234 Abortion spontaneous Diseases 0.000 claims description 3
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims description 3
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 claims description 3
- 206010002199 Anaphylactic shock Diseases 0.000 claims description 3
- 206010003011 Appendicitis Diseases 0.000 claims description 3
- 208000031729 Bacteremia Diseases 0.000 claims description 3
- 206010007559 Cardiac failure congestive Diseases 0.000 claims description 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 3
- 208000015943 Coeliac disease Diseases 0.000 claims description 3
- 206010014824 Endotoxic shock Diseases 0.000 claims description 3
- 206010019280 Heart failures Diseases 0.000 claims description 3
- 206010020751 Hypersensitivity Diseases 0.000 claims description 3
- 206010028851 Necrosis Diseases 0.000 claims description 3
- 206010033645 Pancreatitis Diseases 0.000 claims description 3
- 206010033799 Paralysis Diseases 0.000 claims description 3
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims description 3
- 206010040047 Sepsis Diseases 0.000 claims description 3
- 206010040070 Septic Shock Diseases 0.000 claims description 3
- 208000007107 Stomach Ulcer Diseases 0.000 claims description 3
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 claims description 3
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims description 3
- 208000026935 allergic disease Diseases 0.000 claims description 3
- 230000007815 allergy Effects 0.000 claims description 3
- 208000003455 anaphylaxis Diseases 0.000 claims description 3
- 208000006673 asthma Diseases 0.000 claims description 3
- 208000000718 duodenal ulcer Diseases 0.000 claims description 3
- 230000002496 gastric effect Effects 0.000 claims description 3
- 208000006454 hepatitis Diseases 0.000 claims description 3
- 231100000283 hepatitis Toxicity 0.000 claims description 3
- 208000003243 intestinal obstruction Diseases 0.000 claims description 3
- 208000015994 miscarriage Diseases 0.000 claims description 3
- 208000031225 myocardial ischemia Diseases 0.000 claims description 3
- 230000017074 necrotic cell death Effects 0.000 claims description 3
- 206010034674 peritonitis Diseases 0.000 claims description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 3
- 208000020431 spinal cord injury Diseases 0.000 claims description 3
- 208000000995 spontaneous abortion Diseases 0.000 claims description 3
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims description 3
- 206010001889 Alveolitis Diseases 0.000 claims description 2
- 208000024827 Alzheimer disease Diseases 0.000 claims description 2
- 208000004881 Amebiasis Diseases 0.000 claims description 2
- 206010001980 Amoebiasis Diseases 0.000 claims description 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims description 2
- 201000001320 Atherosclerosis Diseases 0.000 claims description 2
- 208000027496 Behcet disease Diseases 0.000 claims description 2
- 208000009137 Behcet syndrome Diseases 0.000 claims description 2
- 206010006448 Bronchiolitis Diseases 0.000 claims description 2
- 206010006895 Cachexia Diseases 0.000 claims description 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 2
- 208000011231 Crohn disease Diseases 0.000 claims description 2
- 201000003883 Cystic fibrosis Diseases 0.000 claims description 2
- 208000001490 Dengue Diseases 0.000 claims description 2
- 206010012310 Dengue fever Diseases 0.000 claims description 2
- 206010014561 Emphysema Diseases 0.000 claims description 2
- 208000000289 Esophageal Achalasia Diseases 0.000 claims description 2
- 206010016228 Fasciitis Diseases 0.000 claims description 2
- 201000006353 Filariasis Diseases 0.000 claims description 2
- 201000005569 Gout Diseases 0.000 claims description 2
- 208000017604 Hodgkin disease Diseases 0.000 claims description 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims description 2
- 206010020843 Hyperthermia Diseases 0.000 claims description 2
- 208000024781 Immune Complex disease Diseases 0.000 claims description 2
- 201000009906 Meningitis Diseases 0.000 claims description 2
- 208000009525 Myocarditis Diseases 0.000 claims description 2
- 206010029240 Neuritis Diseases 0.000 claims description 2
- 206010030136 Oesophageal achalasia Diseases 0.000 claims description 2
- 208000010191 Osteitis Deformans Diseases 0.000 claims description 2
- 206010031252 Osteomyelitis Diseases 0.000 claims description 2
- 208000027868 Paget disease Diseases 0.000 claims description 2
- 206010035664 Pneumonia Diseases 0.000 claims description 2
- 208000033464 Reiter syndrome Diseases 0.000 claims description 2
- 206010063837 Reperfusion injury Diseases 0.000 claims description 2
- 201000010001 Silicosis Diseases 0.000 claims description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims description 2
- 206010046851 Uveitis Diseases 0.000 claims description 2
- 206010046914 Vaginal infection Diseases 0.000 claims description 2
- 201000008100 Vaginitis Diseases 0.000 claims description 2
- 206010047249 Venous thrombosis Diseases 0.000 claims description 2
- 208000027207 Whipple disease Diseases 0.000 claims description 2
- 201000000621 achalasia Diseases 0.000 claims description 2
- 206010003230 arteritis Diseases 0.000 claims description 2
- 206010003246 arthritis Diseases 0.000 claims description 2
- 206010006451 bronchitis Diseases 0.000 claims description 2
- 208000003167 cholangitis Diseases 0.000 claims description 2
- 201000001352 cholecystitis Diseases 0.000 claims description 2
- 208000031513 cyst Diseases 0.000 claims description 2
- 208000025729 dengue disease Diseases 0.000 claims description 2
- 230000001079 digestive effect Effects 0.000 claims description 2
- 206010014599 encephalitis Diseases 0.000 claims description 2
- 206010014665 endocarditis Diseases 0.000 claims description 2
- 230000002327 eosinophilic effect Effects 0.000 claims description 2
- 210000000918 epididymis Anatomy 0.000 claims description 2
- 201000010063 epididymitis Diseases 0.000 claims description 2
- 201000001155 extrinsic allergic alveolitis Diseases 0.000 claims description 2
- 201000005917 gastric ulcer Diseases 0.000 claims description 2
- 230000003179 granulation Effects 0.000 claims description 2
- 238000005469 granulation Methods 0.000 claims description 2
- 208000022098 hypersensitivity pneumonitis Diseases 0.000 claims description 2
- 208000024326 hypersensitivity reaction type III disease Diseases 0.000 claims description 2
- 230000036031 hyperthermia Effects 0.000 claims description 2
- 206010022000 influenza Diseases 0.000 claims description 2
- 208000028867 ischemia Diseases 0.000 claims description 2
- 201000004792 malaria Diseases 0.000 claims description 2
- 208000027202 mammary Paget disease Diseases 0.000 claims description 2
- 206010028417 myasthenia gravis Diseases 0.000 claims description 2
- 208000004296 neuralgia Diseases 0.000 claims description 2
- 208000008494 pericarditis Diseases 0.000 claims description 2
- 208000028169 periodontal disease Diseases 0.000 claims description 2
- 208000008423 pleurisy Diseases 0.000 claims description 2
- 201000007094 prostatitis Diseases 0.000 claims description 2
- 208000002574 reactive arthritis Diseases 0.000 claims description 2
- 201000003068 rheumatic fever Diseases 0.000 claims description 2
- 206010039083 rhinitis Diseases 0.000 claims description 2
- 201000000306 sarcoidosis Diseases 0.000 claims description 2
- 201000004595 synovitis Diseases 0.000 claims description 2
- 206010043778 thyroiditis Diseases 0.000 claims description 2
- 208000025883 type III hypersensitivity disease Diseases 0.000 claims description 2
- 208000000143 urethritis Diseases 0.000 claims description 2
- 208000006820 Arthralgia Diseases 0.000 claims 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims 1
- 206010011732 Cyst Diseases 0.000 claims 1
- 208000024869 Goodpasture syndrome Diseases 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 208000037357 HIV infectious disease Diseases 0.000 claims 1
- 206010019973 Herpes virus infection Diseases 0.000 claims 1
- 206010061603 Respiratory syncytial virus infection Diseases 0.000 claims 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 claims 1
- 210000001367 artery Anatomy 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000002672 hepatitis B Diseases 0.000 claims 1
- 208000010710 hepatitis C virus infection Diseases 0.000 claims 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
- 208000030925 respiratory syncytial virus infectious disease Diseases 0.000 claims 1
- 201000009890 sinusitis Diseases 0.000 claims 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 2
- 208000009329 Graft vs Host Disease Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 208000024908 graft versus host disease Diseases 0.000 description 2
- 201000010849 intracranial embolism Diseases 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 206010009895 Colitis ischaemic Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 208000010159 IgA glomerulonephritis Diseases 0.000 description 1
- 206010021263 IgA nephropathy Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 206010049567 Miller Fisher syndrome Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 201000001981 dermatomyositis Diseases 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 208000007784 diverticulitis Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 201000008222 ischemic colitis Diseases 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73704505P | 2005-11-15 | 2005-11-15 | |
| US60/737,045 | 2005-11-15 | ||
| PCT/US2006/044329 WO2007059203A2 (en) | 2005-11-15 | 2006-11-15 | Treating inflammatory disorders with antibodies to the alpha-7 nicotinic receptors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009515982A JP2009515982A (ja) | 2009-04-16 |
| JP2009515982A5 true JP2009515982A5 (enExample) | 2010-01-14 |
| JP5303279B2 JP5303279B2 (ja) | 2013-10-02 |
Family
ID=38007280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008541306A Expired - Fee Related JP5303279B2 (ja) | 2005-11-15 | 2006-11-15 | アルファ７ニコチン性受容体に対する抗体を使用した炎症性疾患の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8316104B2 (enExample) |
| EP (1) | EP1957107A2 (enExample) |
| JP (1) | JP5303279B2 (enExample) |
| CN (1) | CN101355967A (enExample) |
| AU (1) | AU2006315420B2 (enExample) |
| CA (1) | CA2629545A1 (enExample) |
| WO (1) | WO2007059203A2 (enExample) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050149364A1 (en) * | 2000-10-06 | 2005-07-07 | Ombrellaro Mark P. | Multifunction telemedicine software with integrated electronic medical record |
| US7238715B2 (en) * | 2002-12-06 | 2007-07-03 | The Feinstein Institute For Medical Research | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists |
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| US7599989B2 (en) * | 2005-01-24 | 2009-10-06 | Microsoft Corporation | System and method for gathering and reporting screen resolutions of attendees of a collaboration session |
| US8316104B2 (en) | 2005-11-15 | 2012-11-20 | California Institute Of Technology | Method and apparatus for collaborative system |
| CN117903302A (zh) | 2005-11-30 | 2024-04-19 | Abbvie 公司 | 抗-Aβ球聚体抗体，其相关产品，生产所述抗体的方法，所述抗体的应用以及使用方法 |
| PT1976877E (pt) | 2005-11-30 | 2014-04-29 | Abbvie Inc | Anticorpos monoclonais contra proteína beta-amilóide e suas utilizações |
| US20070268294A1 (en) * | 2006-05-16 | 2007-11-22 | Stephen Troy Eagen | Apparatus and method for topology navigation and change awareness |
| US20070294404A1 (en) * | 2006-06-15 | 2007-12-20 | International Business Machines Corporation | Method and system for authorization and access control delegation in an on demand grid environment |
| US20080065999A1 (en) * | 2006-09-13 | 2008-03-13 | Majors Kenneth D | Conferencing system with document access |
| US8418069B2 (en) * | 2006-09-29 | 2013-04-09 | International Business Machines Corporation | Spinning off chat threads |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| US9195996B1 (en) | 2006-12-27 | 2015-11-24 | Qurio Holdings, Inc. | System and method for classification of communication sessions in a social network |
| US20100311767A1 (en) | 2007-02-27 | 2010-12-09 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
| US7852819B2 (en) * | 2007-03-01 | 2010-12-14 | Meraki, Inc. | Client operation for network access |
| US9274847B2 (en) * | 2007-05-04 | 2016-03-01 | Microsoft Technology Licensing, Llc | Resource management platform |
| US8782527B2 (en) * | 2007-06-27 | 2014-07-15 | Microsoft Corp. | Collaborative phone-based file exchange |
| SA08290475B1 (ar) * | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
| US7822841B2 (en) * | 2007-10-30 | 2010-10-26 | Modern Grids, Inc. | Method and system for hosting multiple, customized computing clusters |
| EP2056563B1 (en) * | 2007-11-05 | 2012-09-26 | Alcatel Lucent | Peer-to-peer network |
| US9117211B2 (en) * | 2008-07-24 | 2015-08-25 | International Business Machines Corporation | System and method for correlating questions and answers in an instant messaging environment |
| US8655950B2 (en) * | 2008-08-06 | 2014-02-18 | International Business Machines Corporation | Contextual awareness in real time collaborative activity alerts |
| US8838532B2 (en) * | 2008-12-24 | 2014-09-16 | At&T Intellectual Property I, L.P. | Collaborative self-service contact architecture with automatic blog content mapping capability |
| GB2469501B (en) * | 2009-04-16 | 2012-01-04 | Appshare Ltd | Method and system for network-based collaboration |
| US9390156B2 (en) * | 2009-06-29 | 2016-07-12 | International Business Machines Corporation | Distributed directory environment using clustered LDAP servers |
| US20110142221A1 (en) * | 2009-12-15 | 2011-06-16 | At&T Intellectual Property I, L.P. | System and method for automated group calling service based on key words |
| US8508575B2 (en) * | 2010-03-31 | 2013-08-13 | Sony Corporation | Television system, television set and method for operating a television system |
| CN104744591B (zh) | 2010-04-15 | 2022-09-27 | Abbvie德国有限责任两合公司 | β淀粉样蛋白结合蛋白 |
| US9035997B2 (en) | 2010-05-12 | 2015-05-19 | Blue Jeans Network | Systems and methods for real-time multimedia communications across multiple standards and proprietary devices |
| US9081633B2 (en) | 2010-05-24 | 2015-07-14 | Microsoft Technology Licensing, Llc | Remote application connection sharing |
| EP2589183B1 (en) * | 2010-06-29 | 2014-03-26 | Telefonaktiebolaget L M Ericsson (publ) | A method and an apparatus for evaluating network performance |
| US8558868B2 (en) * | 2010-07-01 | 2013-10-15 | Cisco Technology, Inc. | Conference participant visualization |
| EP3533803B1 (en) | 2010-08-14 | 2021-10-27 | AbbVie Inc. | Anti-amyloid-beta antibodies |
| US9124757B2 (en) | 2010-10-04 | 2015-09-01 | Blue Jeans Networks, Inc. | Systems and methods for error resilient scheme for low latency H.264 video coding |
| CA3179622C (en) * | 2010-10-08 | 2025-08-05 | Brian Lee Moffat | Private data sharing system |
| US8380845B2 (en) | 2010-10-08 | 2013-02-19 | Microsoft Corporation | Providing a monitoring service in a cloud-based computing environment |
| US8843632B2 (en) | 2010-10-11 | 2014-09-23 | Microsoft Corporation | Allocation of resources between web services in a composite service |
| US8959219B2 (en) * | 2010-10-18 | 2015-02-17 | Microsoft Technology Licensing, Llc | Dynamic rerouting of service requests between service endpoints for web services in a composite service |
| US8874787B2 (en) | 2010-10-20 | 2014-10-28 | Microsoft Corporation | Optimized consumption of third-party web services in a composite service |
| US9369673B2 (en) | 2011-05-11 | 2016-06-14 | Blue Jeans Network | Methods and systems for using a mobile device to join a video conference endpoint into a video conference |
| US9300705B2 (en) | 2011-05-11 | 2016-03-29 | Blue Jeans Network | Methods and systems for interfacing heterogeneous endpoints and web-based media sources in a video conference |
| US9159037B2 (en) * | 2011-06-14 | 2015-10-13 | Genesys Telecommunications Laboratories, Inc. | Context aware interaction |
| US9195971B2 (en) * | 2011-07-12 | 2015-11-24 | Salesforce.Com, Inc. | Method and system for planning a meeting in a cloud computing environment |
| EP2555141A1 (en) * | 2011-08-03 | 2013-02-06 | Alcatel Lucent | A method, a system, a server, a control element, a computer program and a computer program product for operating a power grid having decentralized control elements |
| EP2761492A4 (en) * | 2011-09-28 | 2015-05-06 | Apperian Inc | COLLECTIVE COMMUNICATION SESSIONS THROUGH A BROADCAST NOTIFICATION NETWORK |
| US20130097244A1 (en) | 2011-09-30 | 2013-04-18 | Clearone Communications, Inc. | Unified communications bridging architecture |
| DE102011117777B3 (de) * | 2011-11-01 | 2013-01-31 | Markus Lehnert | System und Verfahren zur Bestimmung eines bevorzugten Kommunikationskanal |
| EP2629475B1 (en) | 2012-02-16 | 2019-08-28 | BlackBerry Limited | Method and system for obtaining availability status for multiple sip users |
| JP6102575B2 (ja) * | 2013-07-02 | 2017-03-29 | 富士通株式会社 | 性能測定方法、性能測定プログラム及び性能測定装置 |
| US9392079B2 (en) | 2013-07-19 | 2016-07-12 | International Business Machines Corporation | Directory service discovery and/or learning |
| US20150077509A1 (en) | 2013-07-29 | 2015-03-19 | ClearOne Inc. | System for a Virtual Multipoint Control Unit for Unified Communications |
| US20170034235A1 (en) * | 2015-07-27 | 2017-02-02 | Browan Communications Inc. | Electronic device, communication system and method for transmitting/receiving audio and video data |
| US10771508B2 (en) | 2016-01-19 | 2020-09-08 | Nadejda Sarmova | Systems and methods for establishing a virtual shared experience for media playback |
| US9800931B1 (en) * | 2016-06-08 | 2017-10-24 | Cisco Technology, Inc. | Adaptive screen layout for video conferencing |
| US9712570B1 (en) | 2016-09-28 | 2017-07-18 | Atlassian Pty Ltd | Dynamic adaptation to increased SFU load by disabling video streams |
| WO2019036419A1 (en) * | 2017-08-15 | 2019-02-21 | Kalnik Matthew W | NEW NICOTINE BINDING ANTIBODIES |
| CN110151762A (zh) * | 2019-05-19 | 2019-08-23 | 青海大学 | 一种噻虫啉的新用途 |
| EP4309374A1 (en) | 2021-04-19 | 2024-01-24 | Meta Platforms Technologies, Llc | Wrist-wearable device for automatically switching between video and other calling modes based on sensor data at the wrist-wearable device, head-worn wearable devices for use therewith and for coordinated video capturing with the wrist-wearable device, and methods of use thereof |
| US11632454B2 (en) | 2021-04-19 | 2023-04-18 | Meta Platforms Technologies, Llc | Head-worn wearable devices for automatically ceasing the capture of video data, and methods of use thereof |
| CN120457144A (zh) * | 2022-11-10 | 2025-08-08 | 巴斯德研究所 | 产生作为α7烟碱乙酰胆碱受体的沉默和正变构调节剂的抗体 |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5977144A (en) | 1992-08-31 | 1999-11-02 | University Of Florida | Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines |
| EP0659078B1 (en) | 1992-08-31 | 2003-01-15 | University Of Florida Research Foundation, Inc. | Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system |
| UA54375C2 (uk) | 1994-08-24 | 2003-03-17 | Астра Актієболаг | Спіро-азабіциклічні сполуки, способи їх одержання та фармацевтична композиція |
| SE9600683D0 (sv) | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
| US7266686B1 (en) * | 1996-05-09 | 2007-09-04 | Two-Way Media Llc | Multicasting method and apparatus |
| FR2756826B1 (fr) | 1996-12-05 | 1999-01-08 | Adir | Nouveaux derives tetrahydropyridiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US6323000B2 (en) | 1996-12-20 | 2001-11-27 | Clark A. Briggs | Variant human α7 acetylcholine receptor subunit, and methods of production and uses thereof |
| JP2002502383A (ja) | 1997-05-30 | 2002-01-22 | ニューロサーアチ・アクティーゼルスカブ | ニコチンＡＣｈレセプターに於けるコリン作動性リガンドとしての９−アザビシクロ（３．３．１）ノン−２−エン及びノナン誘導体 |
| AR013184A1 (es) | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
| JP2003512290A (ja) | 1997-09-10 | 2003-04-02 | メルク エンド カムパニー インコーポレーテッド | 家畜抗菌剤としての８ａ−アザライド |
| US6484196B1 (en) * | 1998-03-20 | 2002-11-19 | Advanced Web Solutions | Internet messaging system and method for use in computer networks |
| US6459682B1 (en) * | 1998-04-07 | 2002-10-01 | International Business Machines Corporation | Architecture for supporting service level agreements in an IP network |
| PT1083889E (pt) | 1998-06-01 | 2004-04-30 | Ortho Mcneil Pharm Inc | Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas |
| FR2786769B1 (fr) | 1998-12-04 | 2002-10-25 | Synthelabo | Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique |
| FR2786770B1 (fr) | 1998-12-04 | 2001-01-19 | Synthelabo | Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique |
| US6432975B1 (en) | 1998-12-11 | 2002-08-13 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| SE9900100D0 (sv) | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
| FR2790474B1 (fr) | 1999-03-05 | 2001-04-06 | Synthelabo | Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique |
| GB2349055B (en) * | 1999-04-16 | 2004-03-24 | Mitel Corp | Virtual meeting rooms with spatial audio |
| DE60008866T2 (de) | 1999-05-04 | 2005-01-27 | Neurosearch A/S | Heteroaryl diazabicycloalkene, deren herstellung und verwendung |
| WO2001073446A1 (en) | 2000-03-29 | 2001-10-04 | Synaptica Limited | Alpha 7 nicotinic receptor screening assays |
| US6751404B1 (en) * | 2000-04-13 | 2004-06-15 | Forgent Networks, Inc. | Method and apparatus for detecting processor congestion during audio and video decode |
| GB0010955D0 (en) | 2000-05-05 | 2000-06-28 | Novartis Ag | Organic compounds |
| US6976066B1 (en) * | 2000-05-22 | 2005-12-13 | Microsoft Corporation | Network and method for implementing network platform services for a computing device |
| US6610713B2 (en) | 2000-05-23 | 2003-08-26 | North Shore - Long Island Jewish Research Institute | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| JP2002007294A (ja) * | 2000-06-22 | 2002-01-11 | Canon Inc | 画像配信システム及び方法並びに記憶媒体 |
| WO2002002564A1 (en) | 2000-07-04 | 2002-01-10 | Neurosearch A/S | Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| JP4616971B2 (ja) | 2000-07-18 | 2011-01-19 | 田辺三菱製薬株式会社 | １−アザビシクロアルカン化合物およびその医薬用途 |
| US20030037109A1 (en) * | 2000-08-11 | 2003-02-20 | Newman Harvey B. | Virtual room videoconferencing system |
| US6492385B2 (en) | 2000-08-18 | 2002-12-10 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease |
| US6479510B2 (en) | 2000-08-18 | 2002-11-12 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
| US6492386B2 (en) | 2000-08-18 | 2002-12-10 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
| US6486172B2 (en) | 2000-08-18 | 2002-11-26 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
| WO2002015662A2 (en) | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists |
| WO2002017358A2 (en) | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists) |
| US7158534B2 (en) * | 2000-11-30 | 2007-01-02 | Imajet Communications, Inc. | Unified distributed architecture for a multi-point video conference and interactive broadcast systems |
| ATE385497T1 (de) | 2000-12-01 | 2008-02-15 | Neurosearch As | 3-substituierte quinuclidin-derivate und deren verwendung als nikotinischen agonisten |
| US20020086871A1 (en) | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
| US7130883B2 (en) * | 2000-12-29 | 2006-10-31 | Webex Communications, Inc. | Distributed network system architecture for collaborative computing |
| WO2002057275A1 (en) | 2001-01-17 | 2002-07-25 | University Of Kentucky Research Foundation | Boron-containing nicotine analogs for use in the treatment of cns pathologies |
| US6479172B2 (en) | 2001-01-26 | 2002-11-12 | Xerox Corporation | Electroluminescent (EL) devices |
| US20020133611A1 (en) * | 2001-03-16 | 2002-09-19 | Eddy Gorsuch | System and method for facilitating real-time, multi-point communications over an electronic network |
| CA2341952A1 (en) | 2001-03-23 | 2002-09-23 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases |
| US6569865B2 (en) | 2001-06-01 | 2003-05-27 | Astrazeneca Ab | Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine |
| EP1419161A1 (en) | 2001-08-24 | 2004-05-19 | PHARMACIA & UPJOHN COMPANY | Substituted-heteroaryl-7-aza 2.2.1]bicycloheptanes for the treatment of disease |
| JP2005527472A (ja) | 2001-09-12 | 2005-09-15 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 疾患治療のための置換された７−アザ［２．２．１］ビシクロヘプタン |
| NZ531786A (en) | 2001-10-02 | 2006-10-27 | Upjohn Co | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| WO2003032897A2 (en) | 2001-10-16 | 2003-04-24 | Astrazeneca Ab | Azabicyclic compounds for the treatment of fibromyalgia syndrome |
| US6849620B2 (en) | 2001-10-26 | 2005-02-01 | Pfizer Inc | N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| BR0214016A (pt) | 2001-11-09 | 2004-10-13 | Upjohn Co | Compostos azabicìclico-fenil-fundido heterocìclicos e seu uso como ligandos alfa 7 nachr |
| KR100411251B1 (ko) * | 2001-11-28 | 2003-12-18 | 한국전자통신연구원 | 제한조건을 만족하는 다중 경로 배정방법 |
| DE10211415A1 (de) | 2002-03-15 | 2003-09-25 | Bayer Ag | Bicyclische N-Biarylamide |
| EP1581223B2 (en) * | 2002-12-06 | 2016-05-25 | The Feinstein Institute for Medical Research | Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| US7238715B2 (en) | 2002-12-06 | 2007-07-03 | The Feinstein Institute For Medical Research | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists |
| US7680920B2 (en) * | 2003-03-24 | 2010-03-16 | Netiq Corporation | Methods, systems and computer program products for evaluating network performance using diagnostic rules identifying performance data to be collected |
| US7415527B2 (en) * | 2003-06-13 | 2008-08-19 | Satyam Computer Services Limited Of Mayfair Centre | System and method for piecewise streaming of video using a dedicated overlay network |
| US8316104B2 (en) | 2005-11-15 | 2012-11-20 | California Institute Of Technology | Method and apparatus for collaborative system |
-
2006
- 2006-11-14 US US11/559,881 patent/US8316104B2/en active Active
- 2006-11-15 EP EP06837656A patent/EP1957107A2/en not_active Withdrawn
- 2006-11-15 JP JP2008541306A patent/JP5303279B2/ja not_active Expired - Fee Related
- 2006-11-15 AU AU2006315420A patent/AU2006315420B2/en not_active Ceased
- 2006-11-15 WO PCT/US2006/044329 patent/WO2007059203A2/en not_active Ceased
- 2006-11-15 CA CA002629545A patent/CA2629545A1/en not_active Abandoned
- 2006-11-15 CN CNA2006800503150A patent/CN101355967A/zh active Pending
- 2006-11-15 US US12/224,648 patent/US8524866B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009515982A5 (enExample) | ||
| JP2004510695A5 (enExample) | ||
| JP2005522457A5 (enExample) | ||
| JP2015521039A5 (enExample) | ||
| JP2007514746A5 (enExample) | ||
| JP2016536347A5 (enExample) | ||
| CN110177785A (zh) | 一种二氢异喹啉类化合物 | |
| TW200800018A (en) | Hydrazide compound and pesticidal use of the same | |
| JP2015523323A5 (enExample) | ||
| WO2006066066A3 (en) | Chimeric vectors | |
| JP2010502545A5 (enExample) | ||
| WO2006086350A3 (en) | Improved glass stability, glass forming ability, and microstructural refinement | |
| BR112014020123B1 (pt) | Composto 3-(sulfin/sulfonimidoil) benzamida, composição herbicida, seus usos e método para o controle de plantas indesejadas | |
| JP2014207914A5 (enExample) | ||
| JP2007515489A5 (enExample) | ||
| WO2014157596A1 (ja) | アミジン化合物及びその用途 | |
| JP2009527484A5 (enExample) | ||
| JP2017520598A5 (enExample) | ||
| JP2007514638A5 (enExample) | ||
| JP2017113024A5 (enExample) | ||
| JP2012523460A5 (enExample) | ||
| JP2018191634A5 (enExample) | ||
| JP2008542461A5 (enExample) | ||
| JP2010053171A5 (enExample) | ||
| WO2014002111A1 (en) | Process of preparation of azimsulfuron |